An Evaluation of a C-Glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonist
The C-Glucuronide conjugate 14 was evaluated for its glucocorticoid receptor antagonist activity, metabolic stability, and ability to target the liver.
References (20)
- et al.
J. Biol. Chem.
(1997) - et al.
J. Am. Chem. Soc.
(1999) - et al.
Curr. Med. Chem.
(2003) - et al.
Endocrine Rev.
(1996) Physiol. Rev.
(1984)- et al.
Diabetes
(1996) - et al.
Endocrine Rev.
(1993) - et al.
Ann. Reports Med. Chem.
(2002) - et al.
J. Clin. Endocrinol. Metab.
(1990) - et al.
J. Clin. Endocrinol. Metab.
(1994)
There are more references available in the full text version of this article.
Cited by (14)
Discovery of liver selective non-steroidal glucocorticoid receptor antagonist as novel antidiabetic agents
2012, Bioorganic and Medicinal Chemistry LettersMineralocorticoid receptor is involved in the regulation of genes responsible for hepatic glucose production
2006, Biochemical and Biophysical Research CommunicationsCitation Excerpt :In addition, systemic GR blockade can be problematic in stress situations where increased cortisol levels are required. To overcome these issues, several attempts have been made to target GR antagonists such as RU-486 to liver [24]. Since RU-486 is also a progesterone antagonist used as an abortifacide, the pharmaceutical development path for these approaches is also challenging.
Recent Advances in Therapeutic Approaches toType 2 Diabetes
2005, Annual Reports in Medicinal ChemistryBile acid conjugates of a nonsteroidal glucocorticoid receptor modulator
2004, Bioorganic and Medicinal Chemistry LettersOptimization and metabolic stabilization of a class of nonsteroidal glucocorticoid modulators
2004, Bioorganic and Medicinal Chemistry LettersSynthesis, activity, metabolic stability, and pharmacokinetics of glucocorticoid receptor modulator-statin hybrids
2004, Bioorganic and Medicinal Chemistry Letters
Copyright © 2003 Elsevier Science Ltd. All rights reserved.